Cytomegalovirus (CMV) MicroRNA Expression in Vivo and Immune Evasion Correlates
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00677482|
Recruitment Status : Unknown
Verified May 2015 by Deepali Kumar, University of Alberta.
Recruitment status was: Active, not recruiting
First Posted : May 14, 2008
Last Update Posted : May 27, 2015
|Condition or disease|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||30 participants|
|Official Title:||Cytomegalovirus (CMV) microRNA Expression in Vivo and Immune Evasion Correlates|
|Study Start Date :||April 2008|
|Estimated Primary Completion Date :||July 2016|
|Estimated Study Completion Date :||December 2016|
Solid organ transplant recipients with both asymptomatic CMV viremia, and symptomatic CMV disease are eligible for inclusion in the study. THis includes liver, kidney, heart, pancreas, lung, intestinal and combined transplant recipients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00677482
|University of Alberta Hospital|
|Edmonton, Alberta, Canada, T6G-2E1|
|Principal Investigator:||Atul Humar, MD||University of Alberta|